19 May 2013
Keywords: Sanofi-Aventis, Genzyme, Plavix
Article | 16 September 2010
Chris Viehbacher, chief executive of French drug major Sanofi-Aventis, has made clear that he will pursue his takeover target US ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.